The Oncology Pharmacist
Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".
First Name *
Last Name *
Email Address *
Email Address (Verify) *
We will request your mailing address on the next page.
We will request your mailing address on the next page.

  • Home
  • Issues
    • 2021
      • January 2021 - Vol 14 No 1
    • 2020
      • November 2020, Vol 13, No 6
      • September 2020 - Vol 13 no 5
      • July 2020 - Vol 13 no 4
      • May 2020 - Vol 13 no 3
      • March 2020 - Vol 13 no 2
      • January 2020 - Vol 13 No 1
    • 2019
      • November 2019 - Vol 12 No 4
      • August 2019 - Vol 12 No 3
      • May 2019 - Vol 12 No 2
      • February 2019 - Vol 12 No 1
    • 2018
      • November 2018 - Vol 11 No 3
      • August 2018 - Vol 11 No 2
      • May 2018 - Vol 11 No 1
    • Issue Archive
  • Special Issues
    • Supplements
      • ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
    • Guide to New FDA Approvals
      • 2019 Fourth Annual Guide
      • 2018 Third Annual Guide
      • 2017 Second Annual Guide
      • 2016 First Annual Guide
  • Categories
  • Conference Correspondent
    • Year End Review 2019
  • Web Exclusives
    • Ovarian Cancer Overview
    • All Web Exclusives
    • Drug Updates
    • FDA Approvals, News & Updates
    • In the News
    • Interview with the Innovators
    • Press Releases
    • Online First
    • Media Library
      • Videos
      • Audiocasts
  • Quick Quiz
  • CE
  • About
    • About TOP
    • Advertise
    • Editorial Board
    • Contact Us
    • Resources
    • Submit
      • Author Guidelines
The Oncology Pharmacist

Matthew P. Goetz, MD

Oncologist
Mayo Clinic
Rochester, MN
Authored Items
Questions About Treating Patients Using a CDK4/6 Inhibitor
Matthew P. Goetz, MD
Conference Correspondent  in Breast Cancer, Video, SABCS
The Use of Chemotherapy in the Metastatic Setting
Matthew P. Goetz, MD
Conference Correspondent  in Breast Cancer, Video, SABCS
The Mechanism of Action of CDK4/6 Inhibitors
Matthew P. Goetz, MD
Conference Correspondent  in Breast Cancer, Video, SABCS
CDK4/6 Inhibitors in HER2+ Metastatic Breast Cancer
Matthew P. Goetz, MD
Conference Correspondent  in Breast Cancer, Video, SABCS
Abemaciclib, Ribociclib, or Palbociclib for HR+ Metastatic Breast Cancer?
Matthew P. Goetz, MD
Conference Correspondent  in Breast Cancer, Video, SABCS
Last modified: December 5, 2017
 
  • Privacy Policy
  • Terms of Use
  • Home
  • About
  • Subscribe
  • Advertise
  • Contact Us

©2021 Green Hill Healthcare Communications, LLC, an affiliate of The Lynx Group. All rights reserved.
1249 South River Road - Suite 202, Cranbury, NJ 08512

  • Home
  • Issues
    • 2021
      • January 2021 - Vol 14 No 1
    • 2020
      • November 2020, Vol 13, No 6
      • September 2020 - Vol 13 no 5
      • July 2020 - Vol 13 no 4
      • May 2020 - Vol 13 no 3
      • March 2020 - Vol 13 no 2
      • January 2020 - Vol 13 No 1
    • 2019
      • November 2019 - Vol 12 No 4
      • August 2019 - Vol 12 No 3
      • May 2019 - Vol 12 No 2
      • February 2019 - Vol 12 No 1
    • 2018
      • November 2018 - Vol 11 No 3
      • August 2018 - Vol 11 No 2
      • May 2018 - Vol 11 No 1
    • Issue Archive
  • Special Issues
    • Supplements
      • ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
    • Guide to New FDA Approvals
      • 2019 Fourth Annual Guide
      • 2018 Third Annual Guide
      • 2017 Second Annual Guide
      • 2016 First Annual Guide
  • Categories
  • Conference Correspondent
    • Year End Review 2019
  • Web Exclusives
    • Ovarian Cancer Overview
    • All Web Exclusives
    • Drug Updates
    • FDA Approvals, News & Updates
    • In the News
    • Interview with the Innovators
    • Press Releases
    • Online First
    • Media Library
      • Videos
      • Audiocasts
  • Quick Quiz
  • CE
  • About
    • About TOP
    • Advertise
    • Editorial Board
    • Contact Us
    • Resources
    • Submit
      • Author Guidelines